BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 6
• 7
• 8
• 9
• 10
• 13
• 14
• 15
• 16
• 17
• 20
• 21
• 22
• 23
• 24
• 27
• 28
• 29
• 30
• 31

• NeuroScience Associates Announces Expansion, Increases Capacity to Deliver High Quality Neurohistology Services

  July 29, 2009

   · 

  2 min read
• Dose Control LLC’s Patented Tamper-Resistant Programmable Portable Pill Dispenser Awarded KSEF Phase 0 Grant

  July 29, 2009

   · 

  1 min read
• Business

  Ambrilia Biopharma Inc. Implements Further Cost Reduction Measures; Lay-off of Dr. Philippe Calais, President and CEO and Ms. Monique Letourneau, EVP, Finance and CFO

  July 29, 2009

   · 

  3 min read
• Deals

  Sanofi-Aventis (France) to Buy Merial (JOBS) Stake from Merck & Co., Inc. (JOBS) According to Source

  July 29, 2009

   · 

  11 min read
• Biotech Beach

  Helicon Therapeutics (JOBS) Raises $50 Million

  July 29, 2009

   · 

  1 min read
• Deals

  Valeant Pharmaceuticals International to Acquire Tecnofarma, A Mexican Generic Company

  July 29, 2009

   · 

  2 min read
• Business

  Medicis and ReVance Therapeutics, Inc. Announce Agreement for Development of Next-Gen Neurotoxin; Revance to Receive $10M and Additional Milestone Payments of $94M

  July 29, 2009

   · 

  6 min read
• BioForest

  Cell Therapeutics, Inc. Announces Closing of Public Offering of Common Stock and Warrants

  July 29, 2009

   · 

  1 min read
• BioForest

  Cell Therapeutics, Inc. Initiates Process to Obtain Marketing Approval for Pixantrone in Europe

  July 29, 2009

   · 

  1 min read
• Drug Development

  Neurocrine Biosciences, Inc.'s Elagolix Successful in Six Month Lilac Petal Study; Safety and Efficacy Confirmed in Patients With Endometriosis

  July 29, 2009

   · 

  6 min read